Achira’s ACIX 100 is a microfluidics based point-of-care technology platform for immunodiagnostics. The ACIX 100 consists of a fluorescence-based reader and microfluidic cartridges specific to a diagnostic test. The ACIX 100 is designed for low resource environments such as in developing countries where the centralized lab model is not practical. Currently, a menu of tests covering TSH, T3, T4, b-hCG, FSH, LH and Prolactin is available. Tests for infectious diseases is currently under development.
Sensitive. Rapid. Multiplexed.
Meet us at
MicroTAS 2019 | Basel, Switzerland | Oct 27th – 31st | https://microtas2019.org/
Medica 2019 | Dusseldorf, Germany | Nov 18th – 21st | https://www.medica-tradefair.com/
SelectBIO 2019 | Mumbai, India | Sept 12th – 13th | https://selectbioindia.com/conference/?conf=MLC19
Achira provides microfluidics product design and manufacturing services. Achira’s flexible and phased approach will translate your ideas into robust commercial products ready for the market. We can help you develop solutions for your toughest challenges in medical diagnostics, analytical chemistry, cell selection/isolation and next-generation pharmaceutical manufacturing. Our capabilities range from R&D, design and prototyping, assay development to instrumentation, system integration and pilot manufacturing.
ISO 13485 compliant
Achira’s design, development and manufacturing facility are of the highest standards and are fully compliant with the latest ISO 13485:2016 standards for medical devices.
We are a group of motivated individuals who thrive in a high energy and inter-disciplinary environment. If you are a scientist/engineer with a strong background in microfluidics, electronics or biochemistry, we’d love to hear from you. Please send in your resume to email@example.com